Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer

被引:10
作者
Stanciu, Adina Elena [1 ]
Hurduc, Anca Elena [2 ]
Stanciu, Marcel Marian [3 ]
机构
[1] Inst Oncol Bucharest, Dept Carcinogenesis & Mol Biol, 252 Fundeni, Bucharest 022328, Romania
[2] Inst Oncol Bucharest, Dept Nucl Med, Bucharest, Romania
[3] Univ Politeh Bucharest, Dept Elect Engn Fac, Bucharest, Romania
关键词
Amino acids; blood pressure; cardiac pumping; oncology; peptides and proteins; thyroid diagnostics and treatment; thyroid hormones; REMNANT ABLATION; HEART-FAILURE; DISEASE; BIOMARKERS; RISK; RECOMMENDATIONS; HYPOTHYROIDISM; RADIOIODINE; CARCINOMA; EVENTS;
D O I
10.1080/00365513.2016.1230883
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: We aimed to investigate the effects of thyroid hormone withdrawal on N-terminal prohormone forms of atrial natriuretic peptide (NT-proANP) and brain natriuretic peptide (NT-proBNP) during radioiodine therapy in female patients with differentiated thyroid cancer (DTC).Methods: Serum concentrations of thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), NT-proANP and NT-proBNP were measured in 51 female patients with DTC (48.74.2 years) at three time-points: day of radioiodine therapy (t1 - under acute hypothyroidism), 5 days after radioiodine (t2 - under acute hypothyroidism) and 3 months after radioiodine (t3 - under TSH suppression). Thirty healthy euthyroid women served as controls (42.85.6 years).Results: At t1/t2/t3, median NT-proANP was 5.2/1.7/487pmol/L vs. 297.7pmol/L in control group (p<0.001), median NT-proBNP was 50.1/36.5/79.5pmol/L vs. 64.5pmol/L (p<0.001) and median NT-proANP/NT-proBNP ratios was 0.20/0.18/4.81 vs. 4.14 (p<0.001). In acute hypothyroidism, FT3 levels were positively correlated with NT-proANP (r=0.38, p=0.005), NT-proANP/NT-proBNP ratios (r=0.47, p=0.001), heart rate (r=0.39, p=0.005), and negatively with mean arterial blood pressure (r=-0.58, p<0.001).Conclusions: Our results indicate that NT-proANP reflects more accurately direct thyroid hormone effects than NT-proBNP. Thyroid hormone-dependent hemodynamic effects seem to be overlapped on the direct stimulatory effect of thyroid hormones on NT-proANP secretion by cardiac myocytes.
引用
收藏
页码:626 / 631
页数:6
相关论文
共 31 条
[1]   Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging [J].
Bengel, FM ;
Nekolla, SG ;
Ibrahim, T ;
Weniger, C ;
Ziegler, SI ;
Schwaiger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1822-1827
[2]   Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis [J].
Chaker, Layal ;
Baumgartner, Christine ;
den Elzen, Wendy P. J. ;
Ikram, M. Arfan ;
Blum, Manuel R. ;
Collet, Tinh-Hai ;
Bakker, Stephan J. L. ;
Dehghan, Abbas ;
Drechsler, Christiane ;
Luben, Robert N. ;
Hofman, Albert ;
Portegies, Marileen L. P. ;
Medici, Marco ;
Iervasi, Giorgio ;
Stott, David J. ;
Ford, Ian ;
Bremner, Alexandra ;
Wanner, Christoph ;
Ferrucci, Luigi ;
Newman, Anne B. ;
Dullaart, Robin P. ;
Sgarbi, Jose A. ;
Ceresini, Graziano ;
Maciel, Rui M. B. ;
Westendorp, Rudi G. ;
Jukema, J. Wouter ;
Imaizumi, Misa ;
Franklyn, Jayne A. ;
Bauer, Douglas C. ;
Walsh, John P. ;
Razvi, Salman ;
Khaw, Kay-Tee ;
Cappola, Anne R. ;
Voelzke, Henry ;
Franco, Oscar H. ;
Gussekloo, Jacobijn ;
Rodondi, Nicolas ;
Peeters, Robin P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (06) :2181-2191
[3]   Endothelial Function is Not Changed during Short-Term Withdrawal of Thyroxine in Patients with Differentiated Thyroid Cancer and Low Cardiovascular Risk [J].
Chang, Hyuk-Jae ;
Kim, Kyung Won ;
Choi, Sung Hee ;
Lim, Soo ;
Park, Kyoung Un ;
Park, Do Joon ;
Choi, Dong Joo ;
Jang, Hak C. ;
Cho, Bo Youn ;
Park, Young Joo .
YONSEI MEDICAL JOURNAL, 2010, 51 (04) :492-498
[4]  
Christ-Crain M, 2005, SWISS MED WKLY, V135, P549
[5]   Thyroid hormones and the cardiovascular system: Pathophysiology and interventions [J].
Cini, G. ;
Carpi, A. ;
Mechanick, J. ;
Cini, L. ;
Camici, A. ;
Galetta, F. ;
Giardino, R. ;
Russo, M. A. ;
Iervasi, G. .
BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (10) :742-753
[6]   Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality [J].
Collet, Tinh-Hai ;
Gussekloo, Jacobijn ;
Bauer, Douglas C. ;
den Elzen, Wendy P. J. ;
Cappola, Anne R. ;
Balmer, Philippe ;
Iervasi, Giorgio ;
Asvold, Bjorn O. ;
Sgarbi, Jose A. ;
Voelzke, Henry ;
Gencer, Baris ;
Maciel, Rui M. B. ;
Molinaro, Sabrina ;
Bremner, Alexandra ;
Luben, Robert N. ;
Maisonneuve, Patrick ;
Cornuz, Jacques ;
Newman, Anne B. ;
Khaw, Kay-Tee ;
Westendorp, Rudi G. J. ;
Franklyn, Jayne A. ;
Vittinghoff, Eric ;
Walsh, John P. ;
Rodondi, Nicolas .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (10) :799-809
[7]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[8]  
D'Errico Maria P, 2012, Int J Radiat Oncol Biol Phys, V82, pe239, DOI 10.1016/j.ijrobp.2011.03.058
[9]  
Danzi S, 2004, Minerva Endocrinol, V29, P139
[10]   Cellular action of thyroid hormone on the heart [J].
Dillmann, WH .
THYROID, 2002, 12 (06) :447-452